Mettler-Toledo price target lowered to $1,310 from $1,375 at Baird

In This Article:

https://www.tipranks.com/news/the-fly/autolus-therapeutics-upgraded-to-buy-from-neutral-at-goldman-sachs

Baird analyst Catherine Schulte lowered the firm’s price target on Mettler-Toledo (MTD) to $1,310 from $1,375 and keeps a Neutral rating on the shares. The firm said they reported 3Q results ahead of expectations, including stronger Laboratory and services trends. Management continues to frame market conditions as soft, especially in China and industrial applications, despite ongoing signs of stabilization.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on MTD:

Waiting for permission
Allow microphone access to enable voice search

Try again.